查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198379

智能药丸市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Smart Pills Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，智能药丸市场预计将以 10.2% 的复合年增长率增长。

COVID-19 大流行增加了对用于管理 COVID-19 和其他相关疾病患者的智能药丸的需求。 它还刺激了开发智能药丸的研发活动。 例如，根据 2020 年 8 月发表在 International Journal on Emerging Technologies 上的一篇文章，在 COVID-19 大流行的时代，需要开发具有预编程功能的药片供老年人和感染者使用。是一场比赛。 拟议的 PPD（预编程药丸分配器）就是这样一种方法，旨在让他们定期服用药丸。 根据上述消息来源，拟议的预编程药物输送系统设计有一个使用警报和摄像头单元的警报模块，旨在帮助患者定期服药。就是这样一种方法。 此外，根据世界卫生组织在 2022 年发表的一篇论文，小肠粘膜的宏观变化，这在重症 COVID-19 患者中经常发生。 胶囊内窥镜检查是一种用于观察小肠的微创方法，在 COVID-19 的情况下很有用。 因此，由于与智能药丸相关的好处（例如提高效率），预计在大流行后阶段供应商和患者的满意度会提高。

推动智能药丸市场增长的某些因素包括对微创设备的日益偏好、胃肠道疾病发病率的增加以及技术进步。 此外，神经系统疾病、癌症和其他疾病日益加重的负担正在推动医疗环境中对智能药丸的需求。 例如，世界卫生组织 2021 年 9 月更新估计，大约有 5500 万人患有痴呆症，其中 60% 以上生活在低收入和中等收入国家。 同一份文件还报告说，这一数字预计到 2030 年将增加到 7800 万，到 2050 年将增加到 1.39 亿。 随着阿尔茨海默病和痴呆症的增加，患者更容易忘记或错误服药，从而增加了对智能药丸的需求。 因此，全球疾病负担的增加将导致对智能药物输送的需求增加，这最终将在预测期内推动智能药丸市场的增长。

此外，根据 GIE Media, Inc. 于 2021 年 12 月发表的一篇文章，需要使用能见度和运动范围有限的专用工具进行高技能运动，这促使外科团队引入了更高水平的专业知识。 辅助设备包括内窥镜照相机、可视化扫描仪和造影剂注射器。 根据2021年2月发表在IEEE Access上的一篇论文，微创医学具有较低的术后并发症风险、较少的失血量、较短的术后恢復时间以及相关的生理组织创伤，具有体积小的重要临床意义，已成为主流. 这些因素增加了患者对微创手术的偏好，导致智能药丸市场的增长。

因此，上述因素共同归因于所研究的市场在预测期内的增长。 然而，预计智能药丸批准的严格法规和潜在的健康风险将阻碍预测期内的市场增长。

智能药丸市场趋势

预测期内胶囊内镜有望高速增长

胶囊内窥镜检查是一种使用小型无线摄像头拍摄消化道照片的程序。 胶囊内窥镜摄像头装在一个维生素大小的胶囊中，您可以吞嚥。 当胶囊穿过消化道时，相机会拍摄数千张照片，并将它们发送到佩戴在腰带上的记录器中。 随着医疗保健技术的进步，智能药丸可以消除侵入性手术的需要。 智能药丸以各种方式被设计出来，例如电池和机载内存的进步，增加了长期使用的重要性。 根据 Gastroenterology & Endoscopy News 2022 年 3 月发表的一篇文章，胶囊内镜在评估 GI 出血方面具有较高的阳性（94%-97%）和阴性（83%-100%）预测价值，胶囊内镜的结果可能导致内镜37% 至 87% 的患者进行手术干预或改变医疗管理。 因此，由于内窥镜领域的不断发展和对胃肠道疾病准确诊断的需求不断增加，预计所研究的市场在预测期内将出现显着增长。

由于全球公司倾向于智能胶囊，预计该细分市场将呈现健康增长。 例如，Medtronic 提供 PillCam SB1、PillCam SB2、Olympus Endocapsule 和 Endocapsule 10，NaviCam stomach 由 Ankon 开发，而 CapsoCam 由 CapsoVision 在全球市场提供。 市场上的先进技术和产品批准也有望推动该领域的增长。 例如，2021 年 11 月，MEDTRONIC公司宣布美国食品和药物管理局 (FDA) 批准用于远程内窥镜手术的 PillCam Small Bowel 3 系统。 此外，2022 年 7 月，苏格兰卫生研究人员将启动一项耗资 600 万欧元的新项目，使人工智能辅助 (AI) 胶囊内窥镜成为未来肠癌诊断的一部分。 临床胶囊内窥镜检查 (CCE) 使用一种包含摄像头的“智能药丸”，当患者吞服该摄像头时，它会记录通过肠道的图像。

北美有望主导智能药丸市场

北美已成为世界上最大的市场之一，原因包括广泛接受先进的解决方案以简化患者护理、庞大的客户群以及快速增长的老年人口（据信占大多数）。

此外，在专科药品配送中，因人为行为导致的用药错误越来越多。 因此，由于专注于为患者提供有价值的护理，预计美国对智能药丸的需求将会增长。 例如，根据美国国家医学图书馆发表的一篇文章，到 2022 年 7 月，仅美国每年就有 7,000 至 9,000 人死于用药错误。 因此，这一统计数据表明，该国对智能药丸产品的需求越来越大，以避免用药错误。 此外，根据 2022 年阿尔茨海默病事实和数据报告，超过 600 万所有年龄段的美国人患有阿尔茨海默病，到 2022 年，预计将有 650 万 65 岁及以上的美国人患有阿尔茨海默病并与阿尔茨海默病共存。 根据同一数据，在美国 65 岁以上的总人口中，约有九分之一 (10.7%) 患有阿尔茨海默病。 阿尔茨海默病的患病率随着年龄的增长而增加，在 65-74 岁的人群中达到 5.0%。 因此，从统计数据来看，美国对智能药丸的需求预计会增长。

此外，智能药丸设施的开发在美国正在增加，预计将引领市场。 例如，2022 年 3 月，AccelmedPartners 是一家专注于收购和投资美国商业阶段、中低端市场 HealthTech 公司的私募股权公司，将推出完全集成的端到端药房、药物合规性，报告称它已领导向领先的互联医疗解决方案提供商 MedMinder Systems Inc 投资 4000 万美元。

因此，预计上述因素将在预测期内推动该地区的市场增长。

智能药丸市场竞争对手分析

由于公司在全球和区域开展业务，智能药丸市场不景气。 竞争格局包括CapsoVision、Check-Cap、etectRx Inc、HQ Inc、Kingsoft、Koninklijke Philips NV (Medimetrics)、Medtronic PLC、Olympus Medical Technology、Pentax Medical (Hoya)等市场份额较大的知名公司. 包括对少数国际和本地公司的分析

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 越来越喜欢微创设备
    • 增加消化系统疾病的负担
    • 技术进步
  • 市场製约因素
    • 成本因技术进步而增加
    • 潜在的健康风险
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按应用领域
    • 胶囊内窥镜检查
      • 小肠视频胶囊内窥镜
      • 结肠胶囊内窥镜检查
    • 病人监护
    • 给药
  • 疾病适应症
    • 不明原因的消化道出血
    • 克罗恩病
    • 小肠肿瘤
    • 乳糜泻
    • 遗传性息肉病综合征
    • 神经系统疾病
    • 其他适应症
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • CapsoVision Inc.
    • Medtronic PLC
    • Novartis AG
    • Olympus Medical Technology
    • Pentax Medical（Hoya）
    • Koninklijke Philips NV（Medimetrics）
    • CapsoVision Inc.
    • Check-Cap
    • Otsuka Pharmaceutical Co. Ltd
    • Intromedic
    • etectRx Inc.
    • Pixie Scientific
    • HQ Inc.
    • Jinshan Science and Technology

第七章市场机会与未来趋势

简介目录
Product Code: 56614

The Smart Pills Market is expected to register a CAGR of 10.2% over the forecast period.

The COVID-19 pandemic has boosted the demand for smart pills for the management of patients suffering from COVID-19 and other associated disorders. It has also fueled the research and development activities for the development of smart pills. For instance, as per an article published by the International Journal on Emerging Technologies, in August 2020, in times of the COVID-19 pandemic, there was a need to develop a pill with a preprogrammed feature, which will be used by the elderly or infected people. The proposed preprogrammed pill dispenser (PPD) is one such approach that is designed to help them to take their medicines at regular intervals of time. As per the above-mentioned source proposed preprogrammed drug delivery system is designed with an alerting module using an alarm and camera unit, which is one such approach designed to help patients to take their medications at regular intervals of time. Additionally, according to an article published by WHO, in 2022, macroscopic changes in the small intestine mucosa, occurred frequently in severe COVID-19 patients. A minimally invasive alternative for studying the small intestine is the use of capsule endoscopy, which is useful in the context of COVID-19. Therefore, owing to the advantages associated with smart pills, such as improved efficiency, provider and patient satisfaction is anticipated to increase in the post-pandemic phase.

Certain factors that are driving the smart pills market growth include increasing preference for minimally invasive devices, increasing incidence of gastrointestinal disorders, and technological advancements. Additionally, the increasing burden of neurological, cancer, and other disorders is driving the demand for smart pills in healthcare settings. For instance, the World Health Organization, September 2021 update, around 55 million people have dementia, with over 60% living in low and middle-income countries. The same source also reports that this number is expected to rise to 78 million by 2030 and 139 million by 2050. With the increasing cases of Alzheimer's and dementia, there are increased chances of patients missing doses of medication or wrong administration leading to an increasing need for smart pills. Thus, the increasing burden of diseases around the globe lead to an increase demand for smart drug delivery eventually driving the growth of smart pill market over the forecast period.

Furthermore, according to an article published by GIE Media, Inc., in December 2021, the need to perform highly skilled actions using specialized tools with limited visibility and motion range has introduced higher levels of expertise for surgical teams. Support equipment includes endoscopic cameras, visualization scanners, contrast injectors, etc. According to an article published in IEEE Access in February 2021, minimally invasive medicine has become mainstream because of its crucial clinical significance in providing a low risk of postoperative complications, limited blood loss, short postoperative recovery time, and small sizes of associated physiological tissue wounds. These factors have led to an increased preference for minimally invasive surgeries among patients leading to the smart pills market growth.

Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However stringent regulations for the approval of smart pills and potential health risks are expected to hinder market growth over the forecast period.

Smart Pills Market Trends

Capsule Endoscopy is Expected to Witness High Growth Over the Forecast Period

Capsule endoscopy is a procedure that uses a tiny wireless camera to take pictures of your digestive tract. A capsule endoscopy camera sits inside a vitamin-size capsule you swallow. As the capsule travels through your digestive tract, the camera takes thousands of pictures that are transmitted to a recorder you wear on a belt around your waist. With the advent of healthcare technology, smart pills are capable of eliminating the need for invasive procedures. Various advances are being undertaken in smart pills, such as advances in batteries and onboard memory, which are making them significant for long-term usage. According to an article published by Gastroenterology & Endoscopy News, in March 2022, capsule endoscopy has a high positive (94%-97%) and negative (83%-100%) predictive value in the evaluation of GI bleeding, and findings on capsule endoscopy can lead to endoscopic or surgical intervention or a change in medical management in 37% to 87% of patients. Hence, it is anticipated that the market under study would experience significant growth over the forecast period due to ongoing developments in the field of endoscopy and the growing demand for accurate diagnoses of gastrointestinal illnesses.

Owing to the global companies inclining toward the smart capsule, the segment is expected to witness healthy growth. For instance, Medtronic provides PillCam SB1, PillCam SB2, Olympus provides Endocapsule and Endocapsule 10, NaviCam Stomach is developed by Ankon whereas, CapsoCam is provided by CapsoVision in the global markets. Advance technologies and product approvals in the market are also expected to drive segment growth. For instance, In November 2021, Medtronic plc announced the United States Food and Drug Administration (FDA) clearance for its PillCam Small Bowel 3 system for remote endoscopy procedures. Additionally, in July 2022, Scottish health researchers launched a new EUR 6 million project to make Artificial Intelligence-assisted (AI) capsule endoscopy a part of future bowel cancer diagnostics. Clinical Capsule Endoscopy (CCE) utilizes a 'smart pill' containing cameras that, once swallowed by a patient, records images of the intestines as it passes through.

North America is Expected to Dominate the Smart Pills Market

North America has dominated the global market studied, owing to the factors, such as the wide acceptance of technologically advanced solutions to make patient care hassle-free, a large pool of customers, and a rapidly growing geriatric population.

There is an increase in medication errors caused by human interaction in the distribution of specialty drugs. Thus, to focus on providing value-based care to patients in the United States the demand for smart pills is expected to grow. For instance, as per an article published by the National Library of Medicine, in July 2022, 7,000 to 9,000 persons each year in the United States alone die as a result of drug mistakes. Thus, the statistics indicate that there has been a rising need for smart pill products in the country to avoid medication errors. Additionally, as per the 2022 Alzheimer's Disease facts and figures report, more than 6 million Americans of all ages have Alzheimer's, and an estimated 6.5 million Americans aged 65 and older will be living with Alzheimer's in 2022. The same source reports that out of the total US population, about 1 in 9 people (10.7%) age 65 and older have Alzheimer's dementia. The percentage of people with Alzheimer's dementia increases with age, with 5.0% of people aged 65 to 74. Thus, the statistics indicate that the demand for smart pills is expected to rise in the United States.

Furthermore, the increase development of smart pill facilities in the United States is expected to drive the market. For instance, in March 2022, AccelmedPartners, a private equity firm, focused on acquiring and investing in the US commercial stage, lower middle market HealthTechcompanies, reported that it led a USD 40 million investment in MedMinder Systems Inc., the leading fully-integrated, end-to-end pharmacy, medication adherence, and connected care solution for elderly and polypharmacy patients.

Therefore, the factors mentioned above are expected to drive market growth in the region during the forecast period.

Smart Pills Market Competitor Analysis

The smart pills market is moderate due to the presence of companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold significant market shares and are well known including CapsoVision, Check-Cap, etectRx Inc., HQ Inc., Jinshan Science and Technology, Koninklijke Philips NV (Medimetrics), Medtronic PLC, Olympus Medical Technology, Pentax Medical (Hoya), among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for Minimally-invasive Devices
    • 4.2.2 Rising Burden of Gastrointestinal Disorders
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Increasing Cost with Technological Advancements
    • 4.3.2 Potential Health Risks
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Application Area
    • 5.1.1 Capsule Endoscopy
      • 5.1.1.1 Small Bowel Video Capsule Endoscopy
      • 5.1.1.2 Colon Capsule Endoscopy
    • 5.1.2 Patient Monitoring
    • 5.1.3 Drug Delivery
  • 5.2 By Disease Indication
    • 5.2.1 Occult GI Bleeding
    • 5.2.2 Crohn's Disease
    • 5.2.3 Small Bowel Tumors
    • 5.2.4 Celiac Disease
    • 5.2.5 Inherited Polyposis Syndromes
    • 5.2.6 Neurological Disorders
    • 5.2.7 Other Disease Indications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 CapsoVision Inc.
    • 6.1.2 Medtronic PLC
    • 6.1.3 Novartis AG
    • 6.1.4 Olympus Medical Technology
    • 6.1.5 Pentax Medical (Hoya)
    • 6.1.6 Koninklijke Philips NV (Medimetrics)
    • 6.1.7 CapsoVision Inc.
    • 6.1.8 Check-Cap
    • 6.1.9 Otsuka Pharmaceutical Co. Ltd
    • 6.1.10 Intromedic
    • 6.1.11 etectRx Inc.
    • 6.1.12 Pixie Scientific
    • 6.1.13 HQ Inc.
    • 6.1.14 Jinshan Science and Technology

7 MARKET OPPORTUNITIES AND FUTURE TRENDS